Warfarin might raise the risk of joint replacement: study
The analysis in people with AF suggests a NOAC might be the better option for those at risk of osteoarthritis, authors say
AusDoc brings you the latest news from the American College of Rheumatology virtual congress 2020.
Taking the vitamin K antagonist warfarin appears to raise the risk of having a knee or hip replacement by 57%, compared to being on a non-vitamin K oral anticoagulant (NOAC), a study shows.
The findings suggest that patients with, or at risk of, osteoarthritis (OA) who require oral anticoagulant therapy might fare better if they are prescribed a NOAC, the authors say.
Data from the Health Improvement Network, a UK database of general practice medical records representative of the population, was used to see whether the type of oral anticoagulant affected the risk of hip or knee replacement.
